Product Description

RELIPOIETIN 4000 IU INJ contains Recombinant Human Erythropoietin Alfa 4000 IU, an erythropoiesis stimulating agent that helps stimulate red blood cell production. It is used for the management of certain types of anemia associated with chronic kidney disease, cancer treatment, and other medical conditions where red blood cell production is reduced.

🔹 Key Uses

Treatment of anemia associated with chronic kidney disease

Treatment of anemia caused by certain cancer treatments

Reduction of the need for red blood cell transfusions in selected patients

Management of anemia in certain medical conditions as prescribed by a doctor

🔹 Composition

Recombinant Human Erythropoietin Alfa 4000 IU

🔹 How It Works

Erythropoietin is a natural hormone that stimulates the bone marrow to produce red blood cells. Recombinant erythropoietin alfa works similarly to naturally produced erythropoietin and helps increase red blood cell production when the body does not produce enough erythropoietin.

🔹 Key Benefits

Helps increase red blood cell production

Helps improve hemoglobin levels in appropriate patients

May reduce the need for blood transfusions in selected patients

Supports the management of anemia associated with certain chronic conditions

🔹 Dosage and Administration

The dose and treatment schedule depend on the underlying condition, hemoglobin level, response to treatment, and other medical factors. RELIPOIETIN 4000 IU INJ is administered by subcutaneous or intravenous injection according to the medical indication and healthcare professionals instructions. Regular blood tests may be required during treatment.

🔹 Possible Side Effects

High blood pressure

Headache

Fever

Nausea

Joint or muscle pain

Injection site reactions

Blood clots

Flu like symptoms

🔹 Precautions and Warnings

RELIPOIETIN 4000 IU INJ should be used under qualified medical supervision.

Blood pressure and hemoglobin levels should be monitored regularly during treatment.

Erythropoietin medicines can increase the risk of blood clots, heart attack, stroke, and other cardiovascular complications, particularly when hemoglobin levels become too high.

Inform the doctor about high blood pressure, heart disease, history of blood clots, or seizures before treatment.

Iron levels may need to be assessed because adequate iron is important for an effective response to treatment.

Do not change the dose or treatment schedule without medical advice.

Seek immediate medical attention for chest pain, sudden difficulty breathing, severe headache, weakness on one side of the body, or swelling and pain in an arm or leg.